Contract developer and contract manufacturer of respiratory metered dose inhalers,dry powder inhalers,nasal sprays, topical aerosols and sterile products More
BioBridge® helps clients take advantage of innovations in life sciences, including pharma and healthtech products for humans and animals, agrifood and biotech, from development to market More
Healthpoint focuses on the research, development, and marketing of branded pharmaceuticals, over-the-counter drugs, and medical devices worldwide. More
CollaGenex is developing dermatological applications of its proprietary IMPACS™ technology. Oracea™ (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More
SkinMedica's Mission is to build a specialty skin care pharmaceutical company by developing, acquiring and commercializing patented cosmeceutical and pharmaceutical products. More
All rights reserved. Terms and Conditions | Contact us
